Home » Nephros Enters Into Hemodiafilter Agreement With Asahi Kasei
Nephros Enters Into Hemodiafilter Agreement With Asahi Kasei
Nephros announced it has entered into an agreement with Asahi Kasei Medical, a business unit of Asahi Kasei, granting Asahi Kasei Medical exclusive rights to manufacture and distribute filter products based on the Nephros OLpur MD190 hemodiafilter in Japan for 10 years. In addition to an initial license fee, royalties and milestone payments, Asahi Kasei Medical will make an investment in Nephros common stock.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct